Validation of BRACS to European Portuguese

Centro Hospitalar de Entre o Douro e Vouga16 enrolled

Overview

The goal of this observational study is to translate and validate the fiberoptic endoscopic evaluation of swallowing scale "The Boston Residue and Clearance Scale - BRACS" to European Portuguese

The Boston Residue and Clearance Scale (BRACS) is a multidimensional scale developed and validated to assess the severity of residues observed during fiberoptic endoscopic evaluation of swallowing (FEES). It differs from other FEES residue scales, since it considers all aspects related to pharyngolaryngeal residues, specifically, the location, amount and the patient's clearance ability. The purpose of this study was to translate and cross-culturally adapt the English version of the BRACS into European Portuguese and to investigate the reliability and validity of the translated version of the scale.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Deglutition Disorders Swallowing Disorder Dysphagia, Oropharyngeal

Interventions

FEESOTHER

Single group

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * FEES recording that allowed good visualisation of the pharynx and larynx. * FEES recording of patients after head and neck surgery who had anatomical alterations of the structures, but which did not interfere with good visualisation of the residues. * FEES recording of patients with a tracheostomy or under tube feeding. Exclusion Criteria: * FEES recording of patients under 18 years of age.

Locations (1)

Centro Hospitalar de Entre Douro e Vouga

Santa Maria da Feira, Portugal

Outcomes

Primary Outcomes

Reliable and validated European Portuguese version of the BRACS

Demonstrating the reliability and validity of the Boston Residue and Clearance Scale in diagnosing dysphagia during fiberoptic endoscopic assessment of swallowing examination. BRACS it's an 11-point ordinal residue classification scale that assesses 3 aspects: the amount and location of pharyngolaryngeal residues, the presence of spontaneous swallowing to clear it and the effectiveness of patient's swallowing.

Time frame: patients with neurological and/or mechanical oropharyngeal dysphagia evaluated FEES up to 3 months after the first symptomatology

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.